San Diego County Behavioral Health Services (BHS) was awarded $29.1 million in state funding that will be used to create new mental health and substance use treatment services in the region. The funding was awarded by the California Department of Health Care Services, which approved two Behavioral Health Continuum Infrastructure Program (BHCIP) grants to the county.

One grant, for $21.1 million, will create the new Substance Use Residential & Treatment Services (SURTS) facility. It will include up to 73 new substance use residential treatment beds and 16 recuperative care beds for adults who are eligible for Medi-Cal . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Mental Health Services

The mental health market is defined as treatment services for mental and emotional health and psychiatric care for individuals of all ages. Mental health services are provided by a wide array of professionals, including certified counselors, psychiatrists, psychologists, neurologists, and social workers. The mental health market is facing new challenges – continued cost pressures on Medicare, Medicaid, and government programs; a shift to value-based care financing models; increased consolidation of health systems; and a push towards tech-enabled, consumer-led interventions. While these challenges may seem immense, the mental health market has experienced numerous shifts over the years from the move to managed care to increased community-based care. Organizations that can adapt to these changes are most likely to succeed.


For pregnant women in the U.S. with opioid use disorder (OUD), outpatient treatment episodes with medications for opioid use disorder (MOUD) were associated with 86% higher odds of six-month treatment retention compared to treatment episodes without MOUD. A recent analysis of 2021 data determined that this translated to a 14.2 percentage point higher adjusted probability of six-month retention among treatment episodes with MOUD (43.1%) compared to those without it (28.9%). The cross-sectional study analyzed 29,981… Read